# Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.

> **NCT03290456** · NA · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 146 (estimated)

## Conditions studied

- Granulomatosis With Polyangitis

## Interventions

- **DRUG:** Prednisone 5mg/day extended of 12 additional months
- **DRUG:** Placebo 5mg/day extended of 12 additionnal months.

## Key facts

- **NCT ID:** NCT03290456
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-20
- **Primary completion:** 2029-10-20
- **Final completion:** 2029-10-20
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03290456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03290456, "Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03290456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*